/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.03%
Natural Gas
+3.59%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.13%
VIX
N/A
Economic Calendar
EUR/USD
-0.03%
Natural Gas
+3.59%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.13%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Bitcoin ETFs: Grayscale’s GBTC Records $380 Million Inflows in 2 Consecutive Days
about 4 hours ago
Disney Surpasses Fiscal Q2 Earnings Expectations
about 9 hours ago
RBA Governor Michele Bullock Pours Cold Water on Rate Hike Chatter
about 14 hours ago
XRP Price Forecast: JPMorgan Cross-Border Payments Could Drive XRP to $1,000, Analyst says
2 days ago
Shiba Inu (SHIB) Overtakes BTC and DOGE as Most-Traded Coin in India
2 days ago
The Week Ahead: The RBA and the BoE in Focus Amidst Shifting Policy Outlooks
3 days ago
Bitcoin Price Forecast: Weak Reaction to Upside Breakout
22 minutes ago
Gold Price Forecast: Sideways Trend Continues, Bear Flag Pattern Signals Potential Decline
26 minutes ago
Natural Gas Price Forecast: Testing Resistance Levels Amidst Bullish Momentum
29 minutes ago
What Does Stagflation Mean for Commodity Prices?
about 1 hour ago
NASDAQ Index, SP500, Dow Jones Forecasts – Dow Jones Is Flat As Disney Falls 9.2%
about 1 hour ago
Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Markets Are Mostly Flat As Traders Ignore Middle East Tensions
about 2 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
NARI
profile
Inari Medical Inc
Follow
NARI
(
Nasdaq - US
)
N/A
42.82
+0.98 (+2.34%)
in
:
usd
•
As of: May 07, 2024 15:59
UTC -4
Open
42.00
High
43.09
Low
41.71
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Inari Medical Inc
CEO
Andrew Hykes
Headquarters
6001 oak canyon, suite 100
irvine, ca 92618, united states
Auditor
BDO USA, P.C.
Employees
1,300
Share Holders
10
Website
www.inarimedical.com
Industry
medical specialties
Sector
health technology
Company Overview
Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S.
Inari Medical Inc
Statistics
Valuation Measures
Market Capitalization
2
2.49B
Enterprise Value
2.45B
Enterprise Value/EBITDA
(ttm)
-148.24
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
5.46
Price to Sales
(ttm)
4.69
Price to Cash
(ytd)
476.67
Profitability
Gross Margin
(ttm)
88.05%
Operating Margin
(ttm)
-1.42%
Profit Margin
(ttm)
-0.30%
Return on Equity
(ttm)
-1.65%
Return on Invested Capital
(ttm)
-0.35%
Return on Assets
(ttm)
-1.23%
Income Statement
Revenue
(ttm)
493.63M
Revenue Per Share
(ttm)
8.52
Gross Profit
(ttm)
434.56M
EBITDA
(ttm)
3
-16.53M
Net Income Avi to Common
(ttm)
-1.64M
Diluted EPS
(ttm)
-0.41
Share Statistics
Beta (5Y Monthly)
0.93
52-Week Change
-34.88%
S&P500 52-Week Change
27.90%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
57.96M
Dividend Yield
0.00%
Float
4
51.98M
%
Held by Insiders
10.60%
%
Held by Institutions
90.98%
Balance Sheet
Total Cash
(mrq)
116.06M
Total Cash Per Share
(mrq)
2.00
Total Debt
(mrq)
0.00
Total Debt/Equity
(mrq)
0.00%
Current Ratio
(mrq)
3.09%
Quick Ratio
(mrq)
2.19%
Book Value Per Share
(mrq)
8.05
Cash Flow
Operating Cash Flow Per Share
(ytd)
0.63
Free Cash Flow
(ytd)
29.73M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker